Inspire Medical Systems Toekomstige groei
Future criteriumcontroles 4/6
Inspire Medical Systems zal naar verwachting groeien in winst en omzet met respectievelijk 34% en 16.1% per jaar. De winst per aandeel zal naar verwachting groeien met 32.8% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.5% zijn.
Belangrijke informatie
34.0%
Groei van de winst
32.8%
Groei van de winst per aandeel
| Medical Equipment winstgroei | 17.1% |
| Inkomstengroei | 16.1% |
| Toekomstig rendement op eigen vermogen | 8.5% |
| Dekking van analisten | Good |
| Laatst bijgewerkt | 12 Nov 2024 |
Recente toekomstige groei-updates
Recent updates
Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07
A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)
Oct 31Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?
Oct 03After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar
Aug 08Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?
Jul 17At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?
Jun 22Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors
May 09Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors
Dec 26Inspire Medical Systems: Time To Wake Up
Nov 17An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued
Nov 13Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?
Sep 05Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?
Aug 10Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing
Jul 16Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Jun 15Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching
May 06Inspire Medical stock rises after guiding revenue above estimates
Jan 09Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 12/31/2026 | 1,123 | 88 | 207 | 207 | 13 |
| 12/31/2025 | 950 | 59 | 167 | 164 | 17 |
| 12/31/2024 | 796 | 40 | 128 | 107 | 17 |
| 9/30/2024 | 756 | 33 | 38 | 78 | N/A |
| 6/30/2024 | 706 | 6 | -9 | 30 | N/A |
| 3/31/2024 | 661 | -16 | 3 | 35 | N/A |
| 12/31/2023 | 625 | -21 | 1 | 25 | N/A |
| 9/30/2023 | 570 | -33 | 8 | 27 | N/A |
| 6/30/2023 | 526 | -41 | 19 | 34 | N/A |
| 3/31/2023 | 466 | -44 | 11 | 23 | N/A |
| 12/31/2022 | 408 | -45 | 2 | 12 | N/A |
| 9/30/2022 | 348 | -50 | -14 | -7 | N/A |
| 6/30/2022 | 301 | -44 | -23 | -18 | N/A |
| 3/31/2022 | 262 | -43 | -27 | -22 | N/A |
| 12/31/2021 | 233 | -42 | -25 | -20 | N/A |
| 9/30/2021 | 201 | -47 | -30 | -25 | N/A |
| 6/30/2021 | 175 | -47 | -38 | -34 | N/A |
| 3/31/2021 | 134 | -57 | -52 | -49 | N/A |
| 12/31/2020 | 115 | -57 | -55 | -53 | N/A |
| 9/30/2020 | 96 | -59 | -57 | -55 | N/A |
| 6/30/2020 | 81 | -57 | -51 | -49 | N/A |
| 3/31/2020 | 87 | -41 | -39 | -37 | N/A |
| 12/31/2019 | 82 | -33 | -36 | -33 | N/A |
| 9/30/2019 | 72 | -29 | -32 | -29 | N/A |
| 6/30/2019 | 64 | -25 | -31 | -30 | N/A |
| 3/31/2019 | 57 | -24 | -24 | -23 | N/A |
| 12/31/2018 | 51 | -22 | -19 | -19 | N/A |
| 9/30/2018 | 44 | -21 | -20 | -19 | N/A |
| 6/30/2018 | 38 | -21 | N/A | -19 | N/A |
| 3/31/2018 | 33 | -20 | N/A | -17 | N/A |
| 12/31/2017 | 29 | -18 | N/A | -16 | N/A |
| 12/31/2016 | 16 | -19 | N/A | -18 | N/A |
| 12/31/2015 | 8 | -21 | N/A | -22 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei INSP ( 34% per jaar) ligt boven de spaarquote ( 2.6% ).
Winst versus markt: De winst van INSP ( 34% per jaar) zal naar verwachting sneller groeien dan de US markt ( 15.3% per jaar).
Hoge groeiwinsten: De winst van INSP zal naar verwachting de komende 3 jaar aanzienlijk groeien.
Omzet versus markt: De omzet van INSP ( 16.1% per jaar) zal naar verwachting sneller groeien dan de markt US ( 8.9% per jaar).
Hoge groei-inkomsten: De omzet van INSP ( 16.1% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen INSP zal naar verwachting over 3 jaar laag zijn ( 8.5 %).